However, interpretation and comparison of results is made difficult by a lack of consistent methodological approaches towards analysing this hormone. New method: This study determined the sample collection and analysis protocols that cause the least amounts of protocol dependant variation in plasma oxytocin concentrations detected by ELISA. The effect of vacutainer type, sample extraction prior to analysis and capture and restraint protocol were investigated while validating an assay protocol for two novel species, C59 mw grey seals (Halichoerus grypus) and harbour seals (Phoca vitulina).

Results: Where samples are 4 extracted prior to analysis, vacutainer type (EDTA mean: 8.25 +/- 0.56 pg/ml, heparin mean: 8.25 +/- 0.62 pg/ml, p = 0.82), time taken to obtain a sample and restraint protocol did not affect the concentration of oxytocin SB525334 order detected. However, concentrations of oxytocin detected in raw plasma samples were significantly higher than those in extracted samples, and varied significantly with vacutainer type (EDTA mean: 534.4 +/- 43.7 pg/ml, heparin mean: 300.9 +/- 19.6 pg/ml, p smaller than 0.001) and capture and restraint methodology. There was no relationship between oxytocin concentrations detected in raw and extracted plasma (p =0.25). Comparison with existing method(s): Over half the reviewed published

studies analysing plasma oxytocin use raw plasma and different vacutainer types are used without consistency or justification through-out the literature. Conclusions: We caution that studies using raw plasma are likely to over estimate oxytocin concentrations, cannot be used to accurately infer true values via correlations and are susceptible to variation according vacutainer type. (c) 2014 Elsevier B.V. All rights reserved.”
“Exposure to di(2-ethylhexyl) phthalate Selleck β-Nicotinamide (DEHP) may be related to adverse health effects including developmental and reproductive disorders, prompting interest in strategies for reducing human exposure. We previously reported a reduction

of DEHP metabolite levels in composite urine samples by more than 50% (geometric means) during a 3-day dietary intervention avoiding plastics in food packaging, preparation, and storage. In the present study, we analyzed individual spot urine samples before compositing in order to evaluate temporal variability. There were no meaningful changes in any of the previous findings when using individual rather than composited samples. Individual urine samples, like the composites, showed significant decreases of bigger than = 50% in all three measured DEHP metabolites during the intervention. Compositing urine samples provided sufficient information to observe the effect of the intervention, whereas reducing analytical expenses compared with analyzing multiple samples individually.